Foreign media: China has made significant achievements in the biotechnology sector, with its innovative R&D pipeline and newly approved drugs accounting for more than 30% of the global total. The biotechnology economy in China (including the research and application of life sciences and biotechnology) has contributed more than 7% to the country's GDP.
The report shows that China ranks second in the world in the number of drug developments, gradually narrowing the gap with the United States. In 2024, the Chinese drug regulatory authorities approved a total of 93 new drugs, setting a five-year high; medical device patent applications exceeded 91,500, accounting for 70% of the global total.
In addition, the country has also launched the "Insight System," which is used to integrate R&D, approval, and market data, helping to identify industry opportunities and overcome bottlenecks, accelerating innovation.
Original article: www.toutiao.com/article/1842414043086851/
Statement: This article represents the views of the author himself.